Signal Explorer

Clinical Trial Result Combination Therapy Mentioned Lead Asset Progress Clinical Hold Indication Expansion

Interim Data Positive Patient Retention High Fast Track Designation Received Fast Track Granted Fda Aligned Orphan Status Granted Enrollment Ahead Of Schedule Safety Differentiated Publication Positive Kol Endorsement

Tenant Restoration Obligation Liquidity Position Snapshot Disclosed Depreciation Expense Composition Disclosure Equity Plan Board Approval Conditional On Shareholder Vote Net Loss Reported Rsu Psu Vesting Schedule Disclosed Segment Aggregation Disclosure Codm Segment Reporting Disclosure Financing Activities Cash Flow Disclosure Lease Rou Incremental Borrowing Rate Disclosure Institutional Investment Stock Option Intrinsic Value Disclosure Operating Lease Rent Expense Disclosed Interim Data Positive

Clinical Trial Result

Net Loss Reported Interim Data Positive Publication Positive Patient Retention High Fda Aligned Protocol Amended Enrollment Ahead Of Schedule

Clinical Trial Result Lead Asset Progress Clinical Hold Secondary Endpoint Mentioned Indication Expansion

Clinical Hold Active

Executive Educational Background Disclosure Severance Payment Obligation Executive Severance Change Of Control Fda Aligned Non Solicitation Covenant Interim Data Positive

Clinical Trial Result Lead Asset Progress Clinical Hold

Clinical Trial Result Lead Asset Progress Clinical Hold Combination Therapy Mentioned Indication Expansion

Fda Aligned Patient Retention High Interim Data Positive Publication Positive Safety Differentiated Kol Endorsement Fast Track Granted Protocol Amended

Crl Received Clinical Hold Active

Executive Educational Background Disclosure Severance Payment Obligation Executive Severance Change Of Control Non Solicitation Covenant Change Of Control Definition Kol Endorsement Earnings Call Replay Details Interim Data Positive

Lead Asset Progress Clinical Trial Result

Executive Educational Background Disclosure Equity Plan Board Approval Conditional On Shareholder Vote Non Employee Director Compensation Disclosed Executive Transition Gratitude Statement Director Officer Indemnification Provision Classified Board Director Election Auditor Appointment Ratification Ltip Plan Title Citation Form 8K Filing Disclosure Interim Data Positive Kol Endorsement Publication Positive

Clinical Trial Result Clinical Hold Lead Asset Progress

Liquidity Position Snapshot Disclosed Depreciation Expense Composition Disclosure Net Loss Reported Segment Aggregation Disclosure Tenant Restoration Obligation Codm Segment Reporting Disclosure Fast Track Designation Received Institutional Investment Rsu Psu Vesting Schedule Disclosed Capital Raising Uncertainty Disclosed Fast Track Granted Orphan Status Granted Interim Data Positive

Clinical Trial Result Indication Expansion

Net Loss Reported Forward Looking Statement Definition Interim Data Positive Enrollment Ahead Of Schedule Fda Aligned

Clinical Trial Result Lead Asset Progress Clinical Hold Indication Expansion

Patient Retention High Interim Data Positive Kol Endorsement Enrollment Ahead Of Schedule Fast Track Granted Fast Track Designation Received

Clinical Trial Result Lead Asset Progress Clinical Hold

Ind Submission Planned

Management Exodus Regulatory Designation Only Clinical Trial Result Combination Therapy Mentioned Indication Expansion Clinical Hold Lead Asset Progress

Fast Track Designation Received Fast Track Granted Publication Positive Interim Data Positive Protocol Amended

Crl Received Orphan Drug Designation Clinical Hold Active